Hints and tips:
...“I would say that, as a team, we've pretty well discounted a uniform V-shaped recovery. The question is, is it U-shaped, is it W-shaped or parts of it L-shaped?”...
...DD’s Indap v NYU’s Damodaran: Is stock compensation good or bad?...
...More than one dozen insider trading convictions were subsequently set aside, including that of SAC Capital portfolio manager Michael Steinberg and six of his firm’s analysts....
...That leaves chief executive Michael O’Leary to exploit creative vagueness himself....
...Analysts at Morgan Stanley have said palbociclib could top Pfizer’s blockbuster Lipitor drug at its peak if successful....
...Pfizer was down 2.7 per cent to $20.23, leading the losses in the healthcare sector, as the drugmaker said it was considering spinning off its animal health and nutritional unit to focus on the pharmaceutical...
...Cosmetics makers such as Clarins and L’Oréal had started reporting weakening demand that would flow back to suppliers such as Croda, said Cazenove....
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
...THE WORLD IS FLAT by Thomas L....
...The life assurer fell 1.9 per cent to 103p after Citigroup cut its recommendation from “buy” to “hold”, noting that L&G's embedded value assumptions “appear aggressive”....
International Edition